Drug intelligence / Profile preview

Bioflex F

Development stage: Unknown
Lead developer: Jbklab
Modality: Small Molecules
Administration: Oral

Overview

Bioflex F is a dietary supplement developed by JBK Lab under the CellMed brand, a South Korean pharmacy-exclusive nutritional line. Formulated as oral granules (fine granules), it is designed to support joint and musculoskeletal health. The product typically incorporates a blend of vitamins and minerals, such as Vitamin D and Manganese, alongside JBK Lab's proprietary plant-based complexes (often involving anthocyanins from Aronia). It is marketed as part of the OCNC (Optimal Cell Nutrition Corti-therapy) approach, which focuses on cellular-level nutritional support to manage chronic conditions and maintain structural health.

Brand names: Bioflex F비오플렉스 에프 세립
Other names: Bioflex F granules

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Bioflex F.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioflex F.

Explore the full profile